
### [NCIT:C7709](http://purl.obolibrary.org/obo/NCIT_C7709)
**Label:** Digestive System Neuroendocrine Tumor G1

**Subclasses:** [NCIT:C5547](http://purl.obolibrary.org/obo/NCIT_C5547) (Rectal Neuroendocrine Tumor G1), [NCIT:C6428](http://purl.obolibrary.org/obo/NCIT_C6428) (Descending Colon Neuroendocrine Tumor G1), [NCIT:C6427](http://purl.obolibrary.org/obo/NCIT_C6427) (Ascending Colon Neuroendocrine Tumor G1), [NCIT:C4637](http://purl.obolibrary.org/obo/NCIT_C4637) (Intestinal Neuroendocrine Tumor G1), [NCIT:C6424](http://purl.obolibrary.org/obo/NCIT_C6424) (Meckel Diverticulum Neuroendocrine Tumor G1), [NCIT:C7864](http://purl.obolibrary.org/obo/NCIT_C7864) (Recurrent Digestive System Neuroendocrine Tumor G1), [NCIT:C6426](http://purl.obolibrary.org/obo/NCIT_C6426) (Transverse Colon Neuroendocrine Tumor G1), [NCIT:C5501](http://purl.obolibrary.org/obo/NCIT_C5501) (Cecum Neuroendocrine Tumor G1), [NCIT:C5820](http://purl.obolibrary.org/obo/NCIT_C5820) (Esophageal Neuroendocrine Tumor G1), [NCIT:C96543](http://purl.obolibrary.org/obo/NCIT_C96543) (Anal Canal Neuroendocrine Tumor G1), [NCIT:C6425](http://purl.obolibrary.org/obo/NCIT_C6425) (Duodenal Neuroendocrine Tumor G1), [NCIT:C115245](http://purl.obolibrary.org/obo/NCIT_C115245) (Metastatic Digestive System Neuroendocrine Tumor G1), [NCIT:C7861](http://purl.obolibrary.org/obo/NCIT_C7861) (Localized Digestive System Neuroendocrine Tumor G1), [NCIT:C95982](http://purl.obolibrary.org/obo/NCIT_C95982) (Ampulla of Vater Neuroendocrine Tumor G1), [NCIT:C5497](http://purl.obolibrary.org/obo/NCIT_C5497) (Colon Neuroendocrine Tumor G1), [NCIT:C5861](http://purl.obolibrary.org/obo/NCIT_C5861) (Extrahepatic Bile Duct Neuroendocrine Tumor G1), [NCIT:C7862](http://purl.obolibrary.org/obo/NCIT_C7862) (Regional Digestive System Neuroendocrine Tumor G1), [NCIT:C96160](http://purl.obolibrary.org/obo/NCIT_C96160) (Colorectal Neuroendocrine Tumor G1), [NCIT:C4638](http://purl.obolibrary.org/obo/NCIT_C4638) (Small Intestinal Neuroendocrine Tumor G1), [NCIT:C96924](http://purl.obolibrary.org/obo/NCIT_C96924) (Gallbladder Neuroendocrine Tumor G1), 

**Class expressions from DL-Learner:**

- Thing 53.84%
- [NCIT:C60707](http://purl.obolibrary.org/obo/NCIT_C60707) (Neuron-Specific Enolase Positive Neoplastic Cells Present) 52.17%
- [NCIT:C60674](http://purl.obolibrary.org/obo/NCIT_C60674) (Chromogranin A Positive Neoplastic Cells Present) 52.17%
- [NCIT:C36133](http://purl.obolibrary.org/obo/NCIT_C36133) (Well Differentiated Lesion) 52.17%
- [NCIT:C36132](http://purl.obolibrary.org/obo/NCIT_C36132) (Poorly Differentiated Lesion) 52.17%
- [NCIT:C36130](http://purl.obolibrary.org/obo/NCIT_C36130) (Low Grade Lesion) 52.17%
- [NCIT:C35961](http://purl.obolibrary.org/obo/NCIT_C35961) (Low Mitotic Activity) 52.17%
- [NCIT:C28077](http://purl.obolibrary.org/obo/NCIT_C28077) (Grade 1) 52.17%
- [NCIT:C35960](http://purl.obolibrary.org/obo/NCIT_C35960) (High Mitotic Activity) 37.53%
- [NCIT:C35960](http://purl.obolibrary.org/obo/NCIT_C35960) (High Mitotic Activity) and (not ([NCIT:C40174](http://purl.obolibrary.org/obo/NCIT_C40174) (Uterine Corpus Epithelioid Leiomyosarcoma))) 37.53%
- [NCIT:C35960](http://purl.obolibrary.org/obo/NCIT_C35960) (High Mitotic Activity) and (not ([NCIT:C40170](http://purl.obolibrary.org/obo/NCIT_C40170) (Uterine Corpus Diffuse Leiomyomatosis))) 37.53%
- [NCIT:C35960](http://purl.obolibrary.org/obo/NCIT_C35960) (High Mitotic Activity) and (not ([NCIT:C40168](http://purl.obolibrary.org/obo/NCIT_C40168) (Uterine Corpus Lipoleiomyoma))) 37.53%
- [NCIT:C35960](http://purl.obolibrary.org/obo/NCIT_C35960) (High Mitotic Activity) and (not ([NCIT:C40167](http://purl.obolibrary.org/obo/NCIT_C40167) (Uterine Corpus Bizarre Leiomyoma))) 37.53%
- [NCIT:C35960](http://purl.obolibrary.org/obo/NCIT_C35960) (High Mitotic Activity) and (not ([NCIT:C40166](http://purl.obolibrary.org/obo/NCIT_C40166) (Uterine Corpus Myxoid Leiomyoma))) 37.53%
- [NCIT:C35960](http://purl.obolibrary.org/obo/NCIT_C35960) (High Mitotic Activity) and (not ([NCIT:C40165](http://purl.obolibrary.org/obo/NCIT_C40165) (Uterine Corpus Apoplectic Leiomyoma))) 37.53%


